Wolfe Research upgraded Ryan Specialty (RYAN) to Outperform from Peer Perform with a $64 price target after assuming coverage of the name. The firm views the stock’s recent selloff as “significantly overdone.”
Claim 30% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on RYAN:
- Ryan Specialty Group Appoints Michael Bungert to Board
- Ryan Specialty price target lowered to $68 from $71 at Morgan Stanley
- C3 AI downgraded, Capri upgraded: Wall Street’s top analyst calls
- Ryan Specialty initiated with a Buy at Citi
- Cantor rolls out P&C insurance coverage, sees ‘market in transition’